glp 1 and 2 agonist Targeting GLP-1, GIP & GCG in Obesity Type Diabetes Research 𝗧𝗵𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿

In the United States alone, this form of hepatotoxicity accounts for approximately 20% of liver transplant cases and over 600 deaths a year 1,4,5

In this multicenter study conducted across 22 countries, participants (67.6% females and 72% White) received once-weekly subcutaneous administration of CagriSema ( n = 2,108) with dose escalation from 0.25 mg to a maximum of 2.4 mg for each drug, in addition to lifestyle intervention, compared with placebo ( n = 705)

Type 2 diabetes with chronic kidney disease, where kidney protection is the aim

Candidate PRX amino acid sequences were identified based on the presence of at least the PRX domain PF00578, in addition to one or both of PF08534 (AhpC-TSA) and PF10417 (1-cysPrx_C) (Fig